221 related articles for article (PubMed ID: 15784586)
1. The UspA2 protein of Moraxella catarrhalis is directly involved in the expression of serum resistance.
Attia AS; Lafontaine ER; Latimer JL; Aebi C; Syrogiannopoulos GA; Hansen EJ
Infect Immun; 2005 Apr; 73(4):2400-10. PubMed ID: 15784586
[TBL] [Abstract][Full Text] [Related]
2. Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade.
Attia AS; Ram S; Rice PA; Hansen EJ
Infect Immun; 2006 Mar; 74(3):1597-611. PubMed ID: 16495531
[TBL] [Abstract][Full Text] [Related]
3. A conserved tetranucleotide repeat is necessary for wild-type expression of the Moraxella catarrhalis UspA2 protein.
Attia AS; Hansen EJ
J Bacteriol; 2006 Nov; 188(22):7840-52. PubMed ID: 16963572
[TBL] [Abstract][Full Text] [Related]
4. The UspA1 protein and a second type of UspA2 protein mediate adherence of Moraxella catarrhalis to human epithelial cells in vitro.
Lafontaine ER; Cope LD; Aebi C; Latimer JL; McCracken GH; Hansen EJ
J Bacteriol; 2000 Mar; 182(5):1364-73. PubMed ID: 10671460
[TBL] [Abstract][Full Text] [Related]
5. Biofilm formation by Moraxella catarrhalis in vitro: roles of the UspA1 adhesin and the Hag hemagglutinin.
Pearson MM; Laurence CA; Guinn SE; Hansen EJ
Infect Immun; 2006 Mar; 74(3):1588-96. PubMed ID: 16495530
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the Moraxella catarrhalis uspA1 and uspA2 genes and their encoded products.
Cope LD; Lafontaine ER; Slaughter CA; Hasemann CA; Aebi C; Henderson FW; McCracken GH; Hansen EJ
J Bacteriol; 1999 Jul; 181(13):4026-34. PubMed ID: 10383971
[TBL] [Abstract][Full Text] [Related]
7. The emerging pathogen Moraxella catarrhalis interacts with complement inhibitor C4b binding protein through ubiquitous surface proteins A1 and A2.
Nordström T; Blom AM; Forsgren A; Riesbeck K
J Immunol; 2004 Oct; 173(7):4598-606. PubMed ID: 15383594
[TBL] [Abstract][Full Text] [Related]
8. Vitronectin binds to the head region of Moraxella catarrhalis ubiquitous surface protein A2 and confers complement-inhibitory activity.
Singh B; Blom AM; Unal C; Nilson B; Mörgelin M; Riesbeck K
Mol Microbiol; 2010 Mar; 75(6):1426-44. PubMed ID: 20199596
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic effect of isogenic uspA1 and uspA2 mutations on Moraxella catarrhalis 035E.
Aebi C; Lafontaine ER; Cope LD; Latimer JL; Lumbley SL; McCracken GH; Hansen EJ
Infect Immun; 1998 Jul; 66(7):3113-9. PubMed ID: 9632574
[TBL] [Abstract][Full Text] [Related]
10. The levels and bactericidal capacity of antibodies directed against the UspA1 and UspA2 outer membrane proteins of Moraxella (Branhamella) catarrhalis in adults and children.
Chen D; Barniak V; VanDerMeid KR; McMichael JC
Infect Immun; 1999 Mar; 67(3):1310-6. PubMed ID: 10024576
[TBL] [Abstract][Full Text] [Related]
11. A hag mutant of Moraxella catarrhalis strain O35E is deficient in hemagglutination, autoagglutination, and immunoglobulin D-binding activities.
Pearson MM; Lafontaine ER; Wagner NJ; St Geme JW; Hansen EJ
Infect Immun; 2002 Aug; 70(8):4523-33. PubMed ID: 12117964
[TBL] [Abstract][Full Text] [Related]
12. Impact of sequence diversity in the Moraxella catarrhalis UspA2/UspA2H head domain on vitronectin binding and antigenic variation.
Su YC; Hallström BM; Bernhard S; Singh B; Riesbeck K
Microbes Infect; 2013 May; 15(5):375-87. PubMed ID: 23474333
[TBL] [Abstract][Full Text] [Related]
13. Plasmid pWW115, a cloning vector for use with Moraxella catarrhalis.
Wang W; Hansen EJ
Plasmid; 2006 Sep; 56(2):133-7. PubMed ID: 16757025
[TBL] [Abstract][Full Text] [Related]
14. A mutation affecting expression of a major outer membrane protein of Moraxella catarrhalis alters serum resistance and survival in vivo.
Helminen ME; Maciver I; Paris M; Latimer JL; Lumbley SL; Cope LD; McCracken GH; Hansen EJ
J Infect Dis; 1993 Nov; 168(5):1194-201. PubMed ID: 8228353
[TBL] [Abstract][Full Text] [Related]
15. Moraxella catarrhalis Binds Plasminogen To Evade Host Innate Immunity.
Singh B; Al-Jubair T; Voraganti C; Andersson T; Mukherjee O; Su YC; Zipfel P; Riesbeck K
Infect Immun; 2015 Sep; 83(9):3458-69. PubMed ID: 26099590
[TBL] [Abstract][Full Text] [Related]
16. Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529.
Mason KW; Zhu D; Scheuer CA; McMichael JC; Zlotnick GW; Green BA
Vaccine; 2004 Sep; 22(25-26):3449-56. PubMed ID: 15308371
[TBL] [Abstract][Full Text] [Related]
17. Moraxella catarrhalis strain O35E expresses two filamentous hemagglutinin-like proteins that mediate adherence to human epithelial cells.
Balder R; Hassel J; Lipski S; Lafontaine ER
Infect Immun; 2007 Jun; 75(6):2765-75. PubMed ID: 17371858
[TBL] [Abstract][Full Text] [Related]
18. Ionic binding of C3 to the human pathogen Moraxella catarrhalis is a unique mechanism for combating innate immunity.
Nordström T; Blom AM; Tan TT; Forsgren A; Riesbeck K
J Immunol; 2005 Sep; 175(6):3628-36. PubMed ID: 16148107
[TBL] [Abstract][Full Text] [Related]
19. Moraxella catarrhalis outer membrane protein CD elicits antibodies that inhibit CD binding to human mucin and enhance pulmonary clearance of M. catarrhalis in a mouse model.
Liu DF; McMichael JC; Baker SM
Infect Immun; 2007 Jun; 75(6):2818-25. PubMed ID: 17403868
[TBL] [Abstract][Full Text] [Related]
20. Total genome polymorphism and low frequency of intra-genomic variation in the uspA1 and uspA2 genes of Moraxella catarrhalis in otitis prone and non-prone children up to 2 years of age. Consequences for vaccine design?
Hays JP; van der Schee C; Loogman A; Eadie K; Verduin C; Faden H; Verbrugh H; van Belkum A
Vaccine; 2003 Mar; 21(11-12):1118-24. PubMed ID: 12559789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
